510(k) Report

510(k) · Cleared

Recalled · Class II · 2024

Panther Fusion GBS Assay

K181156510(k) TraditionalCleared Jul 27, 201887-day reviewClass I21 CFR 866.3740Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diagenode · NJR Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test

Cleared on Jul 27, 2018 as substantially equivalent to K121539 (Cepheid, 2012) after an 87-day review. Its family tree reaches back 5 generations to 1994. It has been recalled 2 times.

Decided
Jul 27, 2018
Review
87 days
Class
Class I
Product code
NJR
Recalls
2
Predicates
1

Its longest line of descent runs back 5 generations to K936112 (1994). No later device cites it as a predicate yet.

  1. Root · 5 generations backK936112 Strep B OiaBiostar, Inc. · 1994
  2. 4 generations backK991828 Strep B OiaBiostar, Inc. · 1999
  3. 3 generations backK022504 Idi-Strep B AssayInfectio Diagnostic, Inc. · 2002
  4. 2 generations backK062948 Smart GBS and Smartcycle DX System and Software, Version 1.7BCepheid · 2006
  5. 1 generation backK121539 Xpert GBS LB Genexpert DX Systems (GX-I, GX-IV) Genexpert DX Systems…Cepheid · 2012
  6. This deviceK181156 Panther Fusion GBS AssayDiagenode · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K936112Strep B OiaBiostar, Inc.1994—
−4K991828Strep B OiaBiostar, Inc.1999—
−3K022504Idi-Strep B AssayInfectio Diagnostic, Inc.2002—
−2K062948Smart GBS and Smartcycle DX System and Software, Version 1.7BCepheid2006—
−1K121539Xpert GBS LB Genexpert DX Systems (GX-I, GX-IV) Genexpert DX Systems (GX-Xvi)…Cepheid2012—
0 (this device)K181156Panther Fusion GBS AssayDiagenode2018—
FIG. 1 — Lineage of K181156, 1994–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NJR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NJR device

  1. #1 K222638 Xpert® Xpress GBS, GeneXpert® Dx System…score 7.0 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K121539Xpert GBS LB Genexpert DX Systems (GX-I, GX-IV) Genexpert DX Systems (GX-Xvi) Genexpert…
Summary page 7
…Panther Fusion module where PCR amplification and detection occurs. F. SUBSTANTIAL EQUIVALENCE INFORMATION Predicate device Cepheid Xpert® GBS LB (K121539). Comparison with Predicate A comparison of the Panther Fusion GBS assay to the predicate is summarized in Table 3 (similarities…
Cepheid2012—

Also cleared against K121539: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 13, 2024Class IIZ-0907-2025Process controlPotential weak pouch seal on Panther Fusion GBS assay cartridge, causing potential for invalid or incorrect results leading to a possible delay of treatment.
Mar 18, 2022Class IIZ-0877-2022Component change controlSamples, run on a GBS Assay, that have analyte concentrations that are at or near the limit of detection may produce false negative results.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 4 companies; a new generation was cleared every 5.1 years on median.
  • None of the 5 ancestors has a recall.
  • 1 other device also cites its predicate K121539.

How does its category compare?

All NJR devices

NJR Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · NJR

1in 2023

2010: 12011: 12012: 32013: 12015: 12016: 12017: 22018: 32022: 12023: 1
2007high 3 (2012) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NJR

87in 2018

2012: 162 days median2018: 87 days median
2007high 162 (2012) · low 87 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NJR

1in 2025

2007: 12011: 12012: 22015: 12022: 12024: 22025: 1
2007high 2 (2012) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NJR

14in 2024

2014: 12017: 12020: 12021: 22022: 32023: 82024: 14
2007high 14 (2024) · low 0 (2007)2025

MAUDE reports naming product code NJR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—10
20080—00
20090—00
20101—00
20111—10
2012316220
20131—00
20140—01
20151—10
20161—00
20172—01
201838700
20190—00
20200—01
20210—02
20221—13
20231—08
20240—214
20250—10
20260—0—

What is it indicated for?

The Panther Fusion GBS assay is an automated qualitative in vitro diagnostic test utilizing real-time PCR for detection of Group B Streptococcus DNA from either Lim or Carrot enrichment broth cultures of vaginal/rectal swabs from antepartum women following 18-24 hours incubation.

This test is performed on the Hologic Panther Fusion system and is intended to aid in determining the GBS colonization status of antepartum women. This assay does not diagnose or monitor treatment for GBS infections. The Panther Fusion GBS assay does not provide susceptibility results. Culture isolates are needed for performing susceptibility testing as recommended for penicillin-allergic women.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K181156: Panther Fusion GBS Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K181156

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026